Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of protease inhibitors and antiviral agents. Its unique structure, featuring both an amino group and a trifluoromethyl moiety, makes it valuable in medicinal chemistry for enhancing metabolic stability and binding affinity. Commonly employed in the preparation of biologically active compounds where fluorine substitution improves pharmacokinetic properties. Also utilized in the design of enzyme inhibitors due to its ability to mimic transition states in peptide hydrolysis.